Process for the preparation of (S)-2-amino-non-8-enoic acid

US10465216B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10465216-B2
Application numberUS-201816113738-A
CountryUS
Kind codeB2
Filing dateAug 27, 2018
Priority dateOct 3, 2014
Publication dateNov 5, 2019
Grant dateNov 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein is a process for preparing enantioenriched (S)-2-aminonon-8-enoic acid by amination of 2-oxonon-8-enoic acid in the presence of an enzyme and an ammonia source.

First claim

Opening claim text (preview).

We claim: 1. A method for preparing a compound of formula (IV): wherein R 1 is lower alkyl; comprising reacting a reagent of formula (II) with a compound of formula (III), wherein independently for each occurrence R 1 is lower alkyl; and M is selected from Li, MgCl, MgBr, and MgI. 2. The method of claim 1 , wherein R 1 is ethyl. 3. The method of claim 1 , wherein M is MgBr. 4. The method of claim 1 , wherein R 1 is ethyl; and M is MgBr. 5. The method of claim 1 , further comprising hydrolyzing the compound of formula (IV) to produce 2-oxonon-8-enoic acid. 6. The method of claim 2 , further comprising aminating the 2-oxonon-8-enoic acid in the presence of an enzyme and an ammonia source to produce enantioenriched 2-aminonon-8-enoic acid; wherein the enzyme is a leucine dehydrogenase (LeuDH) from Bacillus cereus; the ammonia source comprises an ammonium chloride or ammonium hydroxide buffer solution; and the LeuDH is a wild type LeuDH or a mutant LeuDH having a mutation at position 42 of the LeuDH amino acid sequence.

Assignees

Inventors

Classifications

  • Leucine dehydrogenase (1.4.1.9) · CPC title

  • C12P13/04Primary

    Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10465216B2 cover?
Disclosed herein is a process for preparing enantioenriched (S)-2-aminonon-8-enoic acid by amination of 2-oxonon-8-enoic acid in the presence of an enzyme and an ammonia source.
Who is the assignee on this patent?
Abbvie Inc
What technology area does this patent fall under?
Primary CPC classification C12P13/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).